2m 2m 2m 2m 2m 2m 2m
Biomarin Pharm (BMRN)
NASDAQ
$58.92-$0.29 (-0.48%)
Price as of Jul 13, 2026 7:46 PM EDT- $11.4BMarket Cap
- 1.67%1-Year Change
- BiotechnologyIndustry
Biomarin Pharm (BMRN)
$58.92-$0.29 (-0.48%)
BMRN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $59.20 | ||
Change | +$0.08 (+0.14%) | ||
Open | $59.12 | ||
High | $59.24 | ||
Low | $58.02 | ||
Previous Close | $59.12 | ||
Volume | 1,587,139 | ||
30-Day Average Volume | 1,934,165 | ||
1-Week Change | 0.70% | ||
1-Month Change | 5.81% | ||
1-Year Change | 1.67% | ||
3-Year Change | -30.93% | ||
5-Year Change | -27.36% | ||
Fundamentals | |||
Shares Outstanding | 193.3M | ||
Total Assets | $8.6B | ||
Market Cap | $11.4B | ||
Enterprise Value | $10.6B | ||
Period: QTR TTM FY | |||
Revenue | $760.1M | ||
Net Income | $105.5M | ||
Free Cash Flow | $199.7M | ||
EBIT | $150.8M | ||
EBITDA | $167.2M | ||
Net Working Capital | $3.8B | ||
EPS | $0.54 | ||
Enterprise Value/EBITDA | 64 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 2 | ||
P/E | 109 | ||
PEG | 0 | ||
Price/Free Cash Flow | 57 | ||
Price/Operating Cash Flow | 52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue